Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

SETB. 2016; 50(3): 220-7


Sentinel lymph node biopsy for skin tumors

Selami Serhat Şirvan, Işıl Akgün, Kamuran Zeynep Sevim, Dağhan Dağdelen, Orhan Yenici, Ayşin Karasoy Yeşilada, Memet Yazar, Medeni Volkan Kıyak.




Abstract

Objective: Nodal involvement is important for the prognosis in skin cancers. In the absence of palpable lymph nodes or when the nodal involvement is suspicious, sentinel lymph node biopsy (SLNB) is the preferred method instead of agrressive regional lymph node dissection. In our study we aimed to share our experience regarding SLNB in malignant skin tumors.
Material and Method: From August 2009 to August 2015, 30 patients (17 male, 13 female) aged between 21-81, who underwent SLNB, were analysed retrospectively. 
Results: Thirty-three SLNBs were performed in 30 patients. In all procedures sentinel lymph node was identified and excised successfully. Eight positive sentinel lymph nodes were obtained. Four patients, who had negative SLNB previously, developed symptoms on behalf of metastasis on follow-up, and underwent therapeutic lymph node dissection.
Conclusion: Patients, who have no clinical evidence of nodal involvement but suspicion of nodal status, should undergo SLNB procedure, which has a low morbidity and complication rate.

Key words: Skin cancer, malignant melanoma, blue nevus, sentinel lymph node biopsy, squamous cell carcinoma






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.